Patents by Inventor Fiona A. Harding

Fiona A. Harding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20220112304
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventor: Fiona A. HARDING
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20210017289
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 21, 2021
    Inventor: Fiona A. HARDING
  • ANTI-PD-1 ANTIBODIES AND THEIR USES
    Publication number: 20200317808
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Daniel E.H. AFAR, Fiona A. HARDING, Josue SAMAYOA
  • ANTI-CD25 ANTIBODIES AND THEIR USES
    Publication number: 20200308290
    Abstract: The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.
    Type: Application
    Filed: June 11, 2020
    Publication date: October 1, 2020
    Inventors: Yoshiko AKAMATSU, Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • Anti-PD-1 antibodies and their uses
    Patent number: 10730953
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: August 4, 2020
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Daniel E. H. Afar, Fiona A. Harding, Josue Samayoa
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20200181282
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: February 20, 2020
    Publication date: June 11, 2020
    Inventor: Fiona A. HARDING
  • Anti-OX40 antibodies and their uses
    Patent number: 10604584
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: March 31, 2020
    Assignee: AbbVie Biotherapeutics Inc.
    Inventor: Fiona A. Harding
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20200048363
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: October 24, 2019
    Publication date: February 13, 2020
    Inventor: Fiona A. HARDING
  • Anti-OX40 antibodies and their uses
    Patent number: 10556962
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: February 11, 2020
    Assignee: AbbVie Biotherapeutics Inc.
    Inventor: Fiona A. Harding
  • ANTI-PD-1 ANTIBODIES AND THEIR USES
    Publication number: 20200040098
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: October 22, 2019
    Publication date: February 6, 2020
    Inventors: Daniel E.H. AFAR, Fiona A. HARDING, Josue SAMAYOA
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20180346593
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Inventor: Fiona A. HARDING
  • FC VARIANTS
    Publication number: 20180251565
    Abstract: The present disclosure relates to polypeptide variants having modified Fc domains with altered affinity to Fc receptors.
    Type: Application
    Filed: February 22, 2018
    Publication date: September 6, 2018
    Inventors: Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • Anti-OX40 antibodies and their uses
    Patent number: 10040864
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: August 7, 2018
    Assignee: AbbVie Biotherapeutics Inc.
    Inventor: Fiona A. Harding
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20180194855
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 12, 2018
    Inventor: Fiona A. HARDING
  • ANTI-OX40 ANTIBODIES AND THEIR USES
    Publication number: 20180171023
    Abstract: The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: December 15, 2017
    Publication date: June 21, 2018
    Inventor: Fiona A. HARDING
  • ANTI-PD-1 ANTIBODIES AND THEIR USES
    Publication number: 20180148513
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 31, 2018
    Inventors: Daniel E.H. AFAR, Fiona A. HARDING, Josue SAMAYOA
  • ANTI-PD-1 ANTIBODIES AND THEIR USES
    Publication number: 20180072810
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: September 14, 2017
    Publication date: March 15, 2018
    Inventors: Daniel E.H. AFAR, Fiona A. Harding, Josue Samayoa
  • Anti-PD-1 antibodies and their uses
    Patent number: 9914783
    Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: March 13, 2018
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Daniel E. H. Afar, Fiona A. Harding, Josue Samayoa
  • ANTI-CD25 ANTIBODIES AND THEIR USES
    Publication number: 20170233481
    Abstract: The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.
    Type: Application
    Filed: May 3, 2017
    Publication date: August 17, 2017
    Applicant: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko AKAMATSU, Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • Anti-TNF-alpha antibodies and their uses
    Patent number: 9315573
    Abstract: The present disclosure relates to antibodies directed to the tumor necrosis factor alpha (“TNF-?”) and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-?.
    Type: Grant
    Filed: February 28, 2014
    Date of Patent: April 19, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Fiona A. Harding, Yoshiko Akamatsu, Robert B. Dubridge, David B. Powers